Annual D&A
$4.44 M
-$1.75 M-28.27%
December 31, 2023
Summary
- As of February 7, 2025, VYGR annual depreciation & amortization is $4.44 million, with the most recent change of -$1.75 million (-28.27%) on December 31, 2023.
- During the last 3 years, VYGR annual D&A has risen by +$624.00 thousand (+16.35%).
- VYGR annual D&A is now -28.27% below its all-time high of $6.19 million, reached on December 31, 2022.
Performance
VYGR Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$1.13 M
-$260.00 K-18.68%
September 30, 2024
Summary
- As of February 7, 2025, VYGR quarterly depreciation & amortization is $1.13 million, with the most recent change of -$260.00 thousand (-18.68%) on September 30, 2024.
- Over the past year, VYGR quarterly D&A has dropped by -$203.00 thousand (-15.21%).
- VYGR quarterly D&A is now -59.74% below its all-time high of $2.81 million, reached on March 31, 2022.
Performance
VYGR Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$5.05 M
+$187.00 K+3.84%
September 30, 2024
Summary
- As of February 7, 2025, VYGR TTM depreciation & amortization is $5.05 million, with the most recent change of +$187.00 thousand (+3.84%) on September 30, 2024.
- Over the past year, VYGR TTM D&A has increased by +$614.00 thousand (+13.83%).
- VYGR TTM D&A is now -26.09% below its all-time high of $6.84 million, reached on September 30, 2022.
Performance
VYGR TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
VYGR Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -28.3% | -15.2% | +13.8% |
| 3 y3 years | +16.4% | +35.7% | -18.4% |
| 5 y5 years | +109.8% | +35.7% | -18.4% |
VYGR Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -28.3% | at low | -59.7% | +35.7% | -26.1% | +28.3% |
| 5 y | 5-year | -28.3% | +60.6% | -59.7% | +49.3% | -26.1% | +82.8% |
| alltime | all time | -28.3% | +2313.6% | -59.7% | +764.1% | -26.1% | +3758.8% |
Voyager Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.13 M(-18.7%) | $5.05 M(+3.8%) |
| Jun 2024 | - | $1.39 M(+16.4%) | $4.87 M(+6.7%) |
| Mar 2024 | - | $1.20 M(-10.4%) | $4.56 M(+2.7%) |
| Dec 2023 | $4.44 M(-28.3%) | $1.33 M(+41.3%) | $4.44 M(+12.7%) |
| Sep 2023 | - | $945.00 K(-13.0%) | $3.94 M(-9.1%) |
| Jun 2023 | - | $1.09 M(+1.0%) | $4.34 M(-2.6%) |
| Mar 2023 | - | $1.07 M(+28.9%) | $4.45 M(-28.1%) |
| Dec 2022 | $6.19 M(+19.9%) | $834.00 K(-37.8%) | $6.19 M(-9.5%) |
| Sep 2022 | - | $1.34 M(+11.4%) | $6.84 M(+1.7%) |
| Jun 2022 | - | $1.20 M(-57.2%) | $6.72 M(+0.3%) |
| Mar 2022 | - | $2.81 M(+89.7%) | $6.70 M(+29.8%) |
| Dec 2021 | $5.17 M(+35.3%) | $1.48 M(+21.1%) | $5.17 M(+10.6%) |
| Sep 2021 | - | $1.22 M(+3.3%) | $4.67 M(+3.6%) |
| Jun 2021 | - | $1.19 M(-7.0%) | $4.51 M(+6.1%) |
| Mar 2021 | - | $1.27 M(+29.1%) | $4.25 M(+11.3%) |
| Dec 2020 | $3.82 M(+38.0%) | $987.00 K(-7.1%) | $3.82 M(+6.4%) |
| Sep 2020 | - | $1.06 M(+14.7%) | $3.59 M(+10.7%) |
| Jun 2020 | - | $926.00 K(+10.0%) | $3.24 M(+8.4%) |
| Mar 2020 | - | $842.00 K(+11.1%) | $2.99 M(+8.2%) |
| Dec 2019 | $2.77 M | $758.00 K(+6.0%) | $2.77 M(+6.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $715.00 K(+5.8%) | $2.59 M(+6.1%) |
| Jun 2019 | - | $676.00 K(+9.7%) | $2.44 M(+7.0%) |
| Mar 2019 | - | $616.00 K(+6.4%) | $2.28 M(+7.6%) |
| Dec 2018 | $2.12 M(+32.7%) | $579.00 K(+2.3%) | $2.12 M(+7.2%) |
| Sep 2018 | - | $566.00 K(+9.7%) | $1.97 M(+7.2%) |
| Jun 2018 | - | $516.00 K(+13.2%) | $1.84 M(+6.2%) |
| Mar 2018 | - | $456.00 K(+4.6%) | $1.73 M(+8.7%) |
| Dec 2017 | $1.59 M(+160.6%) | $436.00 K(+0.7%) | $1.59 M(+20.6%) |
| Sep 2017 | - | $433.00 K(+5.9%) | $1.32 M(+26.0%) |
| Jun 2017 | - | $409.00 K(+29.0%) | $1.05 M(+32.4%) |
| Mar 2017 | - | $317.00 K(+93.3%) | $793.00 K(+29.6%) |
| Dec 2016 | $612.00 K(+2.0%) | $164.00 K(+2.5%) | $612.00 K(0.0%) |
| Sep 2016 | - | $160.00 K(+5.3%) | $612.00 K(0.0%) |
| Jun 2016 | - | $152.00 K(+11.8%) | $612.00 K(+1.2%) |
| Mar 2016 | - | $136.00 K(-17.1%) | $605.00 K(+0.8%) |
| Dec 2015 | $600.00 K(+226.1%) | $164.00 K(+2.5%) | $600.00 K(+37.6%) |
| Sep 2015 | - | $160.00 K(+10.3%) | $436.00 K(+58.0%) |
| Jun 2015 | - | $145.00 K(+10.7%) | $276.00 K(+110.7%) |
| Mar 2015 | - | $131.00 K | $131.00 K |
| Dec 2014 | $184.00 K | - | - |
FAQ
- What is Voyager Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Voyager Therapeutics?
- What is Voyager Therapeutics annual D&A year-on-year change?
- What is Voyager Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Voyager Therapeutics?
- What is Voyager Therapeutics quarterly D&A year-on-year change?
- What is Voyager Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Voyager Therapeutics?
- What is Voyager Therapeutics TTM D&A year-on-year change?
What is Voyager Therapeutics annual depreciation & amortization?
The current annual D&A of VYGR is $4.44 M
What is the all time high annual D&A for Voyager Therapeutics?
Voyager Therapeutics all-time high annual depreciation & amortization is $6.19 M
What is Voyager Therapeutics annual D&A year-on-year change?
Over the past year, VYGR annual depreciation & amortization has changed by -$1.75 M (-28.27%)
What is Voyager Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of VYGR is $1.13 M
What is the all time high quarterly D&A for Voyager Therapeutics?
Voyager Therapeutics all-time high quarterly depreciation & amortization is $2.81 M
What is Voyager Therapeutics quarterly D&A year-on-year change?
Over the past year, VYGR quarterly depreciation & amortization has changed by -$203.00 K (-15.21%)
What is Voyager Therapeutics TTM depreciation & amortization?
The current TTM D&A of VYGR is $5.05 M
What is the all time high TTM D&A for Voyager Therapeutics?
Voyager Therapeutics all-time high TTM depreciation & amortization is $6.84 M
What is Voyager Therapeutics TTM D&A year-on-year change?
Over the past year, VYGR TTM depreciation & amortization has changed by +$614.00 K (+13.83%)